Latest Breaking News On - Idorsia pharmaceuticals ltd - Page 1 : vimarsana.com

Idorsia holds its Annual General Meeting of Shareholders

Allschwil, Switzerland – June 13, 2024 At today’s Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland…

United statesSwitzerland generalBart filiusAlain bachmannAndrewc weissSophie kornowskiJean paul clozelMathieu simonSrishti guptaSandy mahatmeIdorsia executive committeeArticles of associationSwiss exchangeIdorsia ltdSrishti gupta committeeIdorsia pharmaceuticals ltd

Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024

Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Switzerland generalUnited statesKrzysztof narkiewiczMarkus schlaichAndrewc weissConvention hallCommittee for medicinal products human useIdorsia pharmaceuticals ltdEuropean society of cardiologySwiss exchangeUniversity of gdanskEuropean society of hypertensionIdorsia ltdHead of the department hypertensionAmerican heart associationHead of investor relations corporate communications

GNW-Adhoc: Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024 ()

GNW-Adhoc: Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024 () | aktiencheck.de

Switzerland generalUnited statesKrzysztof narkiewiczMarkus schlaichAndrewc weissEuropean society of hypertensionHead of the department hypertensionEuropean society of cardiologyHead of investor relations corporate communicationsIdorsia ltdCommittee for medicinal productsIdorsia pharmaceuticals ltdSwiss exchangeConvention hallEuropean commissionUniversity of gdansk

Idorsia Pharmaceuticals Ltd: Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024

Allschwil, Switzerland - May 31, 2024 Idorsia Ltd (SIX: IDIA) today announced that data from the Phase 3 study of aprocitentan, Idorsia's endothelin receptor antagonist, will be presented by Prof.

United statesSwitzerland generalMarkus schlaichAndrewc weissKrzysztof narkiewiczUniversity of gdanskIdorsia pharmaceuticals ltdIdorsia ltdHead of investor relations corporate communicationsAmerican heart associationEuropean society of hypertensionHead of the department hypertensionSwiss exchangeEuropean society of cardiologyEuropean commissionCommittee for medicinal products human use

newratings de

newratings de
newratings.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newratings.de Daily Mail and Mail on Sunday newspapers.

United statesSwitzerland generalMarkus schlaichAndrewc weissIhre freundeKrzysztof narkiewiczEuropean society of hypertensionScientific councilConvention hallHead of the department hypertensionIdorsia ltdEuropean society of hypertension annual meetingEuropean commissionEuropean society of cardiologyAmerican heart associationCommittee for medicinal products